Meserna Therapeutic

Meserna Therapeutics is a biotechnology company focused on developing next-generation mRNA-based therapeutics. The company leverages a proprietary platform designed to enhance the stability, translation efficiency, and delivery of messenger RNA to treat a variety of diseases. Meserna's research and development efforts are primarily directed toward oncology, infectious diseases, and rare genetic disorders. By optimizing the structural components of mRNA, the company aims to create more potent and durable treatments than first-generation RNA therapies. Meserna operates with a global presence, maintaining facilities in both the United States and China.